SEATTLE--(BUSINESS WIRE)--ZymoGenetics, Inc. (NASDAQ:ZGEN) today reported its financial results for the fourth quarter and year ended December 31, 2008. For the fourth quarter, the company’s net loss declined to $9.2 million, or $0.13 per share, from $38.6 million, or $0.56 per share, for the prior year period. For full year 2008, the company reported a net loss of $116.2 million, or $1.69 per share, compared to a net loss of $148.1 million, or $2.17 per share, for the prior year. The decreased losses for the quarter and the year resulted from increases in revenues as well as decreased research and development expenses.
